MIMICS-3D-USA Registry Study

NCT04640597 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-11-16

No results posted yet for this study

Summary

The MIMICS-3D-USA Study is a prospective, multicentre, observational study (non-investigational) of the BioMimics 3D Vascular Stent System that evaluates evaluate safety, effectiveness and device performance within a real-world clinical population of patients undergoing femoropopliteal intervention for the treatment of peripheral artery disease.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

BioMimics 3D Vascular Stent System

Patients with BioMimics 3D Vascular Stent System

Sponsors & Collaborators

  • Veryan Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Nuwani Edirisinghe · Veryan Medical

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-18
Primary Completion
2023-09-04
Completion
2025-09-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04640597 on ClinicalTrials.gov